Cassava Sciences Aktie

2,00 EUR -0,16 EUR -7,54 %

25.07.2025

BMN

2,37 USD -0,16 USD -6,34 %

nachbörslich25.07.2025

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.103,57 Mio. EUR

Div. Rendite0,00%

WKNA2PGL8

ISINUS14817C1071

SymbolSAVA

Cassava Sciences Aktien News

Sortieren:Datum Meistgelesen

01.04.25ZacksDown -39.52% in 4 Weeks, Here's Why Cassava Sciences (SAVA) Looks Ripe for a Turnaround

25.03.25BenzingaCassava Sciences Discontinues Developing Simufilam For Alzheimer's After Another Phase 3 Trial Flop

07.03.25ZacksCassava Sciences (SAVA) Upgraded to Buy: What Does It Mean for the Stock?

WerbungCassava Sciences-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

03.02.25PR NewswireShareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA

31.01.25PR NewswireLost Money on Cassava Sciences, Inc.(SAVA)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

28.01.25PR NewswireSAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit

21.01.25PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA

20.01.25PR NewswireShareholders that lost money on Cassava Sciences, Inc.(SAVA) Urged to Join Class Action - Contact The Gross Law Firm to Learn More

14.01.25PR NewswireClass Action Filed Against Cassava Sciences, Inc. (SAVA) Seeking Recovery for Investors - Contact Levi & Korsinsky

09.01.25PR NewswireShareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA

08.01.25PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA

02.01.25EQS GroupEQS-News: Cassava Sciences, Inc. (SAVA) Investors: February 10, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

02.01.25PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA

31.12.24PR NewswireShareholders that lost money on Cassava Sciences, Inc.(SAVA) should contact Levi & Korsinsky about pending Class Action - SAVA

27.12.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA

25.12.24PR NewswireSAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

20.12.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA

20.12.24PR NewswireFebruary 10, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against SAVA

17.12.24PR NewswireSAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

17.12.24PR NewswireLevi & Korsinsky Notifies Cassava Sciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SAVA

26.11.24ZacksA Post-Mortem on Cassava Sciences

26.11.24BenzingaUnpacking the Latest Options Trading Trends in Cassava Sciences

26.11.24ZacksDown -83.93% in 4 Weeks, Here's Why You Should You Buy the Dip in Cassava Sciences (SAVA)

26.11.24BenzingaCassava Sciences, Zoom, Kohl's, Rivian, Tesla: Why These 5 Stocks Are On Investors' Radars Today

25.11.24BenzingaCassava Sciences Alzheimer's Drug Fails To Hit Primary Goal In Pivotal Study, Pharma Halts Late-Stage Studies

25.11.24BenzingaCassava Sciences, Biohaven And Other Big Stocks Moving Lower In Monday's Pre-Market Session

15.11.24ZacksIs Cassava Sciences (SAVA) Outperforming Other Medical Stocks This Year?

12.11.24ZacksWhat Makes Cassava Sciences (SAVA) a New Buy Stock

05.11.24BenzingaUnpacking the Latest Options Trading Trends in Cassava Sciences

08.10.24BenzingaWhat's Going On With Alzheimer's-Focused Cassava Sciences On Tuesday?

28.09.24MotleyFoolWhy Cassava Sciences Stock Dived by Almost 11% Today

27.09.24BenzingaCassava Sciences Unusual Options Activity

27.09.24BenzingaCassava Sciences, enVVeno Medical And Other Big Stocks Moving Lower In Friday's Pre-Market Session

27.09.24BenzingaSEC Charges Cassava Sciences Over Manipulated Alzheimer's Trial Data, Company And Former Execs Agree To Pay Penalty

27.09.24MarketWatchCassava Sciences settles SEC charges of ‘misleading’ Alzheimer’s trial claims

24.09.24BenzingaCassava Sciences Stock Rises On Interim Safety Review Of Simufilam Phase 3 Trials

07.08.24BenzingaHere's How Much $100 Invested In Cassava Sciences 5 Years Ago Would Be Worth Today

05.08.24BenzingaWhat's Going On With Cassava Sciences Today?

02.08.24BenzingaCassava Sciences Shares Are Trading Higher Today: What You Need To Know

31.07.24BenzingaWhat's Going On With Cassava Sciences Shares Today?

Cassava Sciences News

Cassava Sciences News: auf dieser Seite finden Sie alle Cassava Sciences News und Nachrichten zur Cassava Sciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Cassava Sciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Cassava Sciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.